Clinical trials: Mitochondrial Diseases

Epithelial Ovarian Cancer, Peritoneal Neoplasms

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

• Terminated
• Age: 18 years and older
• Phase 2
• Results posted

Background: Birinapant is an experimental cancer treatment drug. It removes certain proteins in cells, which helps to kill the cells.

Conditions

Epithelial Ovarian Cancer, Peritoneal Neoplasms, Fallopian Tube Neoplasms

Trial name

NCT01681368

Testing

Birinapant (TL32711)

Where

United States

Volunteers

11 people

Sponsor

National Cancer Institute (NCI)